Imagerie des tumeurs osseuses
暂无分享,去创建一个
[1] Fei Yuan,et al. Differentiation of primary chordoma, giant cell tumor and schwannoma of the sacrum by CT and MRI. , 2013, European journal of radiology.
[2] S. Weiss,et al. Soft Tissue Chordomas: A Clinicopathologic Analysis of 11 Cases , 2013, The American journal of surgical pathology.
[3] C. Binkert,et al. Lumbar vertebral chordoma: diffusion-weighted imaging findings are helpful to narrow the differential diagnosis. A case report. , 2013, Clinical imaging.
[4] C. Fletcher,et al. WHO classification of tumours of soft tissue and bone , 2013 .
[5] B. Nahed,et al. Chordoma: current concepts, management, and future directions. , 2012, The Lancet. Oncology.
[6] T. Jacques,et al. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional‐based study , 2011, The Journal of pathology.
[7] Ziya L Gokaslan,et al. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. , 2011, Journal of neurosurgery. Spine.
[8] 西口 智一. Differentiating benign notochordal cell tumors from chordomas : radiographic features on MRI, CT, and tomography , 2011 .
[9] K. Schmid,et al. MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions , 2010, Tumor Biology.
[10] Y. Inoue,et al. Lumbar vertebral chordoma arising from an intraosseous benign notochordal cell tumour: radiological findings and histopathological description with a good clinical outcome. , 2010, The British journal of radiology.
[11] F. Marandino,et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients , 2010, BMC Cancer.
[12] A. Goldstein,et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma , 2009, Nature Genetics.
[13] M. D. den Bakker,et al. Brachyury Expression in Extra-axial Skeletal and Soft Tissue Chordomas: A Marker that Distinguishes Chordoma From Mixed Tumor/Myoepithelioma/Parachordoma in Soft Tissue , 2008, The American journal of surgical pathology.
[14] H. Tsuchiya,et al. Distinguishing benign notochordal cell tumors from vertebral chordoma , 2008, Skeletal Radiology.
[15] Scott M Schuetze,et al. Chordoma: the nonsarcoma primary bone tumor. , 2007, The oncologist.
[16] V. Deshpande,et al. Intraosseous Benign Notochord Cell Tumors (BNCT): Further Evidence Supporting a Relationship to Chordoma , 2007, The American journal of surgical pathology.
[17] S. Henderson,et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas , 2006, The Journal of pathology.
[18] J. Weinstein,et al. Chordoma of the Mobile Spine: Fifty Years of Experience , 2006, Spine.
[19] Y. Ueda,et al. Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors , 2005, Modern Pathology.
[20] Oliver Jäkel,et al. Results of carbon ion radiotherapy in 152 patients. , 2004, International journal of radiation oncology, biology, physics.
[21] A. Goldstein,et al. Chordoma: incidence and survival patterns in the United States, 1973–1995 , 2004, Cancer Causes & Control.
[22] A. Goldstein,et al. Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33. , 2001, American journal of human genetics.
[23] E. Laws,et al. Cranial chordomas in children and young adults. , 1983, Journal of neurosurgery.
[24] R. Volpe,et al. A clinicopathologic review of 25 cases of chordoma: (a pleomorphic and metastasizing neoplasm) , 1983, The American journal of surgical pathology.
[25] R. M. Wynn. The borderland of embryology and pathology , 1964 .